INOVA 2
Alternative Names: INOVA-2Latest Information Update: 21 Mar 2024
At a glance
- Originator InnoRNA
- Developer BeiGene; InnoRNA
- Class Antineoplastics; Immunotherapies; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer